There’s a lot of talk about patient centricity in the clinical trial space these days. But what exactly is changing in the industry to make trials more patient centric? The leadership team at VirTrial has a long history in the clinical research industry and first-hand experience with how trials work. They’ve also seen first-hand where there’s room for improvement. With that said, they are constantly learning from peers about new thoughts and ideas that can help move the industry forward. VirTrial is making a concentrated effort to make this buzz-word a reality. 

VirTrial’s tact is to ask directly. Working in a systematic approach, the company has plans to survey sponsors, sites, and patients to ask specific questions on what would make it easier for patients to participate in trials and then plans to incorporate their findings into their virtual trial solution. 

VirTrial’s Concerted Effort to Improve Patient Centricity

Learn from Industry Studies – Perceptions & Insights study conducted by The Center for Information & Study on Clinical Research Participation found that 85% of respondents believe clinical research is important to the development of new medicines. When asked about whether or not they would participate, physical site location and length of participation were listed as very important deciding factors. Research has also shown that no form of technology can replace human connection. This type of feedback solidifies that a hybrid virtual solution, which combines both virtual and in-person visits, will help reduce the burden of travel time, number of visits and address the absence of human interaction. 

Conduct Independent Studies – VirTrial recently conducted a pilot study which resulted in more than 95% of respondents rating the VirTrial app as “easy” or “very easy” to use when asked about various actions including download and consent, entering information, and initiating a video chat. Based on these very positive results, VirTrial’s next step is to work with a partner to collaborate on a larger pilot study. In this study, we aim to document that a hybrid designed trial with some remote visits and some in person visits will improve the speed of study enrollment as well as improve retention rates.

Actively Participate in Industry Events – On average, someone from the leadership team attends an industry event monthly, and sometimes more. They are often session speakers, panel facilitators, or interviewees. They support the industry via sponsorships and actively engage with conference attendees to glean as much information as possible to develop the best solution on the market. 

Learn from Online Activity – VirTrial representatives actively seek out input and suggestions from across the industry. They are active personally on LinkedIn and through the company page on Facebook and Twitter. The team also proactively searches out feedback from sponsors, site staff, and patients via online forums and other methods. 

Collaborate with Industry Associations – The VirTrial leadership team members are actively involved in industry associations as independent members as well as representatives of VirTrial. The company recently joined the Society for Clinical Research Sites (SCRS) as a Global Impact Partner (GIP) to support site sustainability. 

Take a moment and share your feedback on patient centricity. This is your opportunity to contribute to the evolution of virtual clinical trials and help improve the future of the industry. We value your opinion!